Future of Health is a series of panel discussions where we focus on challenges and possibilities within healthcare. On December 3rd, it is time for our fourth dialogue of the year on the theme of precision medicine. What makes precision medicine possible today? How does Sweden compare with the rest of the world? What new business opportunities open up in the wake of precision medicine?
We are in the midst of a medical revolution. Technological development and intense research help us understand diseases on a more detailed level, and as a result, adapt the medical treatment to the individual. We are shifting from "one size fits all" to target "the right treatments to the right patients at the right time”. Although precision medicine gets a lot of attention, we are probably still many who wonder what the concept actually entails and how it will change healthcare today and in the future.
Panelists
- Richard Rosenquist Brandell, professor of clinical genetics, Karolinska Institutet
- Gerd Lärfars, Docent, Chair of NT-rådet, Head of unit of the pharma department, Region Stockholm Assembly
- Christoph Varenhorst, Country Medical Director, IM Medical Lead, Pfizer
- Karl Bergman, CEO, Elypta
Moderated byAndreas Namslauer and Filippa Kull, Stockholm Science City
When: 08.30-10:00 (breakfast will be served from 08.00)Where: H2 Health Hub, Hälsingegatan 45
The registration is now closed, please contact anna.frejd@ssci.se if you are interested to participate.